UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025090
Receipt number R000028852
Scientific Title The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy
Date of disclosure of the study information 2016/12/01
Last modified on 2020/12/25 16:41:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy

Acronym

The clinical trial to evaluate the efficacy of [11C]K-2 in epilepsy patients

Scientific Title

The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy

Scientific Title:Acronym

The clinical trial to evaluate the efficacy of [11C]K-2 in epilepsy patients

Region

Japan


Condition

Condition

refractory epilepsy patients

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To prove the efficacy of [11C]K-2 in measuring the densities of AMPA receptors

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The correlation of the AMPA receptors densities examined by biochemical study and [11C]K-2 PET study

Key secondary outcomes

The adverse events occured in patients during 7days after PET scan


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

The administration of PET tracer

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.refractory epilepsy patients(mesial temporal lobe epilepsy)
2.patinets for anterior temporal lobectomy(ATL)
3.patients who are without cerebral surgery on the same side of ATL
4.patients who are 20 years or older
5.patients who can consent to this study by oneself

Key exclusion criteria

1.patients who have significant abnormalities insides the brains
2.patients who have experienced the electric stimulation therapy
3.patients who undergo artificial dialysis
4.patients who have severe liver dysfunction
5.patients who have tatoo
6.claustrophobic patients
7.breast-feeding mothers, expecting mothers, females who desire to be a mother
8.patients who desire to bear a child within this study period
9.patients who take Fycompa
10.patients who underwent nuclear medicine examination within one-week before this registarion
11.patients who underwent other clinical trials using unapproved nuclear medicine examination within six month before this registarion
12.patients who underwent other clinical trials within 12 weeks before this registarion
13.patients whom study doctors consider unappropriate

Target sample size

8


Research contact person

Name of lead principal investigator

1st name miyazaki
Middle name
Last name tomoyuki

Organization

Yokohama City University, School of Medicine

Division name

Department of Physiology

Zip code

236-0051

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

045-787-2579

Email

johney@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name sano
Middle name
Last name akane

Organization

Yokohama City University, School of Medicine

Division name

Department of Physiology

Zip code

236-0051

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

045-787-2579

Homepage URL


Email

akane@med.yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University, School of Medicine

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University Certified Institutional Review Board

Address

3-9 Fukuura,kanazawa-ku,Yokohama,Kanagawa , Kanagawa

Tel

045-370-7627

Email

rinri@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

8

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 28 Day

Date of IRB

2016 Year 07 Month 20 Day

Anticipated trial start date

2016 Year 11 Month 28 Day

Last follow-up date

2020 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 11 Month 30 Day

Last modified on

2020 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028852


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name